<DOC>
	<DOC>NCT00503360</DOC>
	<brief_summary>This study will evaluate the tolerability and safety of SAD448 and explore the compound's effect on intraocular pressure in subjects with ocular hypertension.</brief_summary>
	<brief_title>Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Key inclusion criteria: Males and females, 18 65 years of age, with ocular hypertension Females must be postmenopausal or surgically sterile Key exclusion criteria: Diagnosis of glaucoma in either eye A history of or current eye conditions or medical problems that would prohibit the use of an investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Ocular Hypertension</keyword>
	<keyword>SAD448</keyword>
</DOC>